Lung Transplant Infection: Clinical Trials

13 trials for Lung Transplant Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 active not recruiting, 1 not yet recruiting. 3 Phase 2, 2 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Not applicable2Completed 2
Early Phase 11Active not recruiting 1
Phase 11Completed 1
Phase 31Unknown 1

Follow Lung Transplant Infection: new trials by email Literature Review of Lung Transplant Infection trials Research Report on Lung Transplant Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase
Lung Transplant Infection, Pneumonia, Bacterial
Not yet recruitingPoliclinico Hospital202025-07-012025-05-22
Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
cell-free dNA - Lung Transplant Failure and Rejection, Lung Transplant Infection
RecruitingJesper Magnusson1462024-11-152025-09-16
Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
BioFire Pneumonia Panel Plus - Lung Transplant Infection, Molecular Diagnostic
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico532023-02-022023-07-25
AlloSure Lung Assessment and Metagenomics Outcomes Study
Lung Transplant Infection, Lung Transplant; Complications
Active not recruitingCareDx5502021-10-292026-06-25
Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation
Tolsura - Lung Transplant Infection
WithdrawnHong Nguyen2020-12-012023-04-24
The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.
PC945, Standard of Care - Aspergillosis, Lung Transplant Infection
Phase 2TerminatedPulmocide Ltd22019-09-172021-07-16
Transplantation Using Hepatitis C Positive Donors, A Safety Trial
Glecaprevir 300 MG / Pibrentasvir 120 MG Oral Tablet, Ezetimibe 10Mg Oral Tablet, Ex Vivo Lung Perfusion - Lung Transplant Infection, Heart Transplant Infection
Phase 3UnknownJordan Feld402018-08-062019-07-12
Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation
Lung Transplant Infection, Lung Transplant Rejection
UnknownCapital Medical University1002018-08-052018-08-07
Lung Transplant HCV, Pilot Study
Sofosbuvir-velpatasvir (400 mg/100 mg), Ex Vivo Lung Perfusion (EVLP) - Lung Transplant Infection, Hepatitis C
Early Phase 1Active not recruitingUniversity Health Network, Toronto262017-09-192026-05-11
Extracorporeal Photopheresis (ECP) After Lung Transplantation
ECP (Extracorporeal Photopheresis System) - Lung Transplant Infection, Lung Transplant Rejection
Not applicableCompletedMedical University of Vienna622017-03-012024-08-23
Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
Inhaled beclomethasone, Placebo - Lung Transplant Infection
Phase 1 / Phase 2CompletedWashington University School of Medicine162017-02-012022-03-03
Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.
Dornase Alfa, Isotonic Saline. - Lung Transplant Infection, Lower Respiratory Tract Infection
Phase 2CompletedThe Alfred322013-10-312019-08-28
Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients
collection of blood samples for PK testing - Lung Transplant Infection, Fungal Infection
Not applicableCompletedUniversity of Pittsburgh202011-10-012014-12-08

Narrower conditions

Hepatitis C (2)  ·  Rejection, Psychology (2)  ·  Aspergillosis (1)  ·  Bacterial Infections (1)  ·  Infections (1)  ·  Mycoses (1)  ·  Pneumonia (1)  ·  Pneumonia, Bacterial (1)  ·  Postoperative Complications (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Infections (6)  ·  Bacterial Infections and Mycoses (4)  ·  Respiratory Tract Diseases (3)  ·  Behavior (2)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Digestive System Diseases (2)  ·  Flaviviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Liver Diseases (2)  ·  Lung Diseases (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Social Behavior (2)

Interventions

Ezetimibe (1)  ·  Itraconazole (1)  ·  Noninvasive Prenatal Testing (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Tablets (1)  ·  dornase alfa (1)  ·  glecaprevir (1)  ·  pibrentasvir (1)  ·  sofosbuvir-velpatasvir drug combination (1)

Sponsors

Capital Medical University (1)  ·  CareDx (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Hong Nguyen (1)  ·  Jesper Magnusson (1)  ·  Jordan Feld (1)  ·  Medical University of Vienna (1)  ·  Policlinico Hospital (1)  ·  Pulmocide Ltd (1)  ·  The Alfred (1)  ·  University Health Network, Toronto (1)  ·  University of Pittsburgh (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  Canada (3)  ·  Italy (2)  ·  Australia (1)  ·  Austria (1)  ·  China (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Benjamin J Tarrant, B.Physio (1)  ·  Ciara Shaver (1)  ·  Debbie Levine (1)  ·  Hong Nguyen, MD (1)  ·  Jordan Feld, MD, MPH (1)  ·  Marcelo Cypel, MD MSc FRCSC (1)  ·  Ramsey Hachem, MD (1)  ·  Ryan Shields, Pharm D (1)

Results publications

PMID 23173619, PMID 23328523, PMID 24025442, PMID 27143659, PMID 27248293, PMID 27615811, PMID 28729000, PMID 28784324, PMID 31606437, PMID 32389183

NIH funding

2018 (1)